GenHome Array—a CES 2026 Innovation Awards Honoree in Digital Health—is a compact, fully automated molecular diagnostic system that delivers rapid, lab-grade results at point-of-care and emergency settings.
Many healthcare settings struggle with sluggish diagnostic workflows that are reliant on specialized equipment and personnel, delaying critical treatment decisions. GenHome Array eliminates these hurdles: it integrates nucleic acid extraction, RT-LAMP amplification, and result interpretation in under 30 minutes, processes up to eight samples simultaneously, and automatically optimizes conditions using barcode-embedded cartridges.
With a user-friendly interface, automated loading, and high-resolution result quantification, GenHome Array empowers frontline and resource-limited settings to perform precise, multi-pathogen testing quickly and reliably without requiring complex lab equipment or extensively trained personnel.
Automated Molecular Diagnostic Systems
GenHome Array Delivers Trusted Results at the Point of Care
Trend Themes
-
Point-of-care Diagnostics — GenHome Array's ability to deliver rapid, lab-grade results in point-of-care settings transforms how medical professionals approach diagnostics.
-
Automation in Healthcare — By integrating and automating multiple diagnostic processes, GenHome Array diminishes the reliance on specialized personnel and equipment, accelerating the workflow in healthcare facilities.
-
Multi-pathogen Testing — The capacity to conduct precise, simultaneous testing for various pathogens with GenHome Array bolsters the advancement of comprehensive diagnostic systems.
Industry Implications
-
Digital Health — The GenHome Array exemplifies the rising integration of digital solutions in healthcare, providing streamlined and efficient diagnostic alternatives.
-
Medical Devices — GenHome Array represents a breakthrough in medical devices, marrying compact design with high capability for frontline and resource-limited environments.
-
Biotechnology — Biotechnology sees disruptive potential in developing novel molecular diagnostic platforms like GenHome Array that simplify and expedite pathogen detection processes.